Sjögren's syndrome and mixed connective tissue disease. 1992

E Ohtsuka, and S Nonaka, and M Shingu, and M Yasuda, and M Nobunaga
Department of Internal Medicine, Kyushu University, Beppu, Japan.

We investigated the clinical significance of the close association of Sjögren's syndrome (SS) with mixed connective tissue disease (MCTD) by analyzing the clinical manifestations, sialographic findings and immunological parameters of MCTD and primary SS. The prevalence of sialectasia or SS in MCTD was significantly higher than in any other connective tissue diseases. The prevalence of Raynaud's phenomenon, swollen fingers, arthralgias, lymphadenopathy, sclerodactyly, muscle weakness, fever and erythema was significantly higher in MCTD than in primary SS. There were no significant differences between these manifestations in MCTD patients with sialectasia or SS, and those in MCTD patients without sialectasia or SS. Although the levels or prevalence of the erythrocyte sedimentation rate, CRP, antinuclear factor, anti-DNA antibody and anti-RNP antibody were significantly greater in MCTD than in primary SS, there were no significant differences in the levels or the prevalence of laboratory abnormalities between MCTD with sialectasia or SS, and MCTD without sialectasia or SS. Moreover, there was a strict dissociation between the occurrence of anti-RNP antibody and anti-SS-B antibody both in MCTD and primary SS. These results suggest that the association of secondary SS or sialectasia in MCTD, although more common than in other connective tissue diseases, is merely a consequence of MCTD and does not influence the clinical course of MCTD.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008947 Mixed Connective Tissue Disease A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a "speckled" epidermal nuclear staining pattern on direct immunofluorescence. Connective Tissue Disease, Mixed,Sharp Syndrome,MCTD,Syndrome, Sharp
D001799 Blood Sedimentation Measurement of rate of settling of ERYTHROCYTES in blood. Erythrocyte Sedimentation,Erythrocyte Sedimentation Rate,Erythrocyte Sedimentation Rates,Rate, Erythrocyte Sedimentation,Rates, Erythrocyte Sedimentation,Sedimentation Rate, Erythrocyte,Sedimentation Rates, Erythrocyte,Sedimentation, Blood,Sedimentation, Erythrocyte
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000097585 SS-B Antigen Nuclear autoantigens implicated in nascent RNA protection. It is a target of AUTOANTIBODIES in patients with SJOGREN'S SYNDROME. LA Antigen,La(SSB) Antigen,Lupus Antigen La,SS-B La Antigen,Sjogren's Syndrome-B Antigen,SS B Antigen
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear
D001324 Autoantigens Endogenous tissue constituents with the ability to interact with AUTOANTIBODIES and cause an immune response. Autoantigen,Autologous Antigen,Autologous Antigens,Self-Antigen,Self-Antigens,Antigen, Autologous,Antigens, Autologous,Self Antigen,Self Antigens

Related Publications

E Ohtsuka, and S Nonaka, and M Shingu, and M Yasuda, and M Nobunaga
June 1976, The Journal of rheumatology,
E Ohtsuka, and S Nonaka, and M Shingu, and M Yasuda, and M Nobunaga
October 1984, The Journal of rheumatology,
E Ohtsuka, and S Nonaka, and M Shingu, and M Yasuda, and M Nobunaga
February 1985, British journal of rheumatology,
E Ohtsuka, and S Nonaka, and M Shingu, and M Yasuda, and M Nobunaga
March 1978, American journal of diseases of children (1960),
E Ohtsuka, and S Nonaka, and M Shingu, and M Yasuda, and M Nobunaga
March 2014, Clinics (Sao Paulo, Brazil),
E Ohtsuka, and S Nonaka, and M Shingu, and M Yasuda, and M Nobunaga
March 1993, Internal medicine (Tokyo, Japan),
E Ohtsuka, and S Nonaka, and M Shingu, and M Yasuda, and M Nobunaga
January 1989, Acta cientifica venezolana,
E Ohtsuka, and S Nonaka, and M Shingu, and M Yasuda, and M Nobunaga
May 1977, Archives of dermatology,
E Ohtsuka, and S Nonaka, and M Shingu, and M Yasuda, and M Nobunaga
January 2003, Gastroenterologie clinique et biologique,
E Ohtsuka, and S Nonaka, and M Shingu, and M Yasuda, and M Nobunaga
January 1978, Revue de stomatologie et de chirurgie maxillo-faciale,
Copied contents to your clipboard!